State variation in opioid treatment policies and opioid-related hospital readmissions
- PMID: 30558595
- PMCID: PMC6296089
- DOI: 10.1186/s12913-018-3703-8
State variation in opioid treatment policies and opioid-related hospital readmissions
Abstract
Background: State policy approaches designed to provide opioid treatment options have received significant attention in addressing the opioid epidemic in the United States. In particular, expanded availability of naloxone to reverse overdose, Good Samaritan laws intended to protect individuals who attempt to provide or obtain emergency services for someone experiencing an opioid overdose, and expanded coverage of medication-assisted treatment (MAT) for individuals with opioid abuse or dependence may help curtail hospital readmissions from opioids. The objective of this retrospective cohort study was to evaluate the association between the presence of state opioid treatment policies-naloxone standing orders, Good Samaritan laws, and Medicaid medication-assisted treatment (MAT) coverage-and opioid-related hospital readmissions.
Methods: We used 2013-2015 hospital inpatient discharge data from 13 states from the Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project. We examined the relationship between state opioid treatment policies and 90-day opioid-related readmissions after a stay involving an opioid diagnosis.
Results: Our sample included 383,334 opioid-related index hospitalizations. Patients treated in states with naloxone standing-order policies at the time of the index stay had higher adjusted odds of an opioid-related readmission than did those treated in states without such policies; however, this relationship was not present in states with Good Samaritan laws. Medicaid methadone coverage was associated with higher odds of readmission among all insurance groups except Medicaid. Medicaid MAT coverage generosity was associated with higher odds of readmission among the Medicaid group but lower odds of readmission among the Medicare and privately insured groups. More comprehensive Medicaid coverage of substance use disorder treatment and a greater number of opioid treatment programs were associated with lower odds of readmission.
Conclusions: Differences in index hospitalization rates suggest that states with opioid treatment policies had a higher level of need for opioid-related intervention, which also may account for higher rates of readmission. More research is needed to understand how these policies can be most effective in influencing acute care use.
Keywords: Medication-assisted treatment; Opioid abuse; Opioid readmissions; State opioid treatment policies.
Conflict of interest statement
Ethics approval and consent to participate
The HCUP databases are consistent with the definition of limited data sets under the Health Insurance Portability and Accountability Act Privacy Rule and contain no direct patient identifiers. The AHRQ Human Research Protections Program has determined that research using HCUP data has exempt status.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Similar articles
-
Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.JAMA Netw Open. 2021 Feb 1;4(2):e2036687. doi: 10.1001/jamanetworkopen.2020.36687. JAMA Netw Open. 2021. PMID: 33576816 Free PMC article.
-
Readmissions Following Inpatient Treatment for Opioid-Related Conditions.Subst Use Misuse. 2019;54(3):473-481. doi: 10.1080/10826084.2018.1517174. Epub 2019 Jan 8. Subst Use Misuse. 2019. PMID: 30618327
-
Relationship between insurance and 30-day readmission rates in patients 65 years and older discharged from an acute care hospital with hospice services.J Hosp Med. 2016 Oct;11(10):688-693. doi: 10.1002/jhm.2613. Epub 2016 May 25. J Hosp Med. 2016. PMID: 27222206 Review.
-
Coronary artery bypass graft readmission rates and risk factors - A retrospective cohort study.Int J Surg. 2018 Jun;54(Pt A):7-17. doi: 10.1016/j.ijsu.2018.04.022. Epub 2018 Apr 17. Int J Surg. 2018. PMID: 29678620
-
U.S. substance use harm reduction efforts: a review of the current state of policy, policy barriers, and recommendations.Harm Reduct J. 2025 Jun 8;22(1):101. doi: 10.1186/s12954-025-01238-4. Harm Reduct J. 2025. PMID: 40484964 Free PMC article. Review.
Cited by
-
When Effects Cannot be Estimated: Redefining Estimands to Understand the Effects of Naloxone Access Laws.Epidemiology. 2022 Sep 1;33(5):689-698. doi: 10.1097/EDE.0000000000001502. Epub 2022 Jun 24. Epidemiology. 2022. PMID: 35944151 Free PMC article.
-
Awareness and knowledge of the Good Samaritan Drug Overdose Act among people at risk of witnessing an overdose in British Columbia, Canada: a multi-methods cross sectional study.Subst Abuse Treat Prev Policy. 2022 May 25;17(1):42. doi: 10.1186/s13011-022-00472-4. Subst Abuse Treat Prev Policy. 2022. PMID: 35614474 Free PMC article.
-
How simulation modeling can support the public health response to the opioid crisis in North America: Setting priorities and assessing value.Int J Drug Policy. 2021 Feb;88:102726. doi: 10.1016/j.drugpo.2020.102726. Epub 2020 Apr 28. Int J Drug Policy. 2021. PMID: 32359858 Free PMC article. No abstract available.
-
Systematic review of the emerging literature on the effectiveness of naloxone access laws in the United States.Addiction. 2021 Jan;116(1):6-17. doi: 10.1111/add.15163. Epub 2020 Jul 8. Addiction. 2021. PMID: 32533570 Free PMC article.
-
Multilevel Risk Factors for Hospital Readmission Among Patients With Opioid Use Disorder in Selected US States: Role of Socioeconomic Characteristics of Patients and Their Community.Health Serv Res Manag Epidemiol. 2020 Jun 1;7:2333392820904240. doi: 10.1177/2333392820904240. eCollection 2020 Jan-Dec. Health Serv Res Manag Epidemiol. 2020. PMID: 32529001 Free PMC article.
References
-
- National Institute on Drug Abuse, 2017. Overdose death rates. https://wwwdrugabusegov/related-topics/trends-statistics/overdose-death-... Accessed 03 April 17.
-
- Weiss, A.J., Elixhauser, A. Barrett, M.L., Steiner, C.A., Bailey, M.K., O’Malley, L., 2016. Opioid-Related Inpatient Stays and Emergency Department Visits by State, 2009-2014. HCUP statistical brief #219. Agency for Healthcare Research and Quality. http://www.hcup-us.ahrq.gov/reports/statbriefs/sb219-Opioid-Hospital-Sta.... Accessed 27 April 2018.
-
- American Society of Addiction Medicine, 2013. Advancing Access to Addiction Medications: Implications for Opioid Addiction Treatment. http://www.asam.org/docs/default-source/advocacy/aaam_implications-for-o.... Accessed 24 April 2018.
-
- Network of Public Health Law, 2017. Using Law to Support Pharmacy Naloxone Distribution. https://www.networkforphl.org/_asset/qdkn97/Pharmacy-Naloxone-Distributi.... Accessed 24 April 2018.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical